Quick Answer
Fulgent Genetics, Inc. reported Total Assets of $1.21 billion for the year ending 2025.
- Fulgent Genetics, Inc. showed a decrease of -0.5% in Total Assets from 2024 to 2025.
- This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $22.76 million | Q1 2017: $58.82 million | Q2 2017: $58.81 million | Q3 2017: $58.67 million | Q1 2018: $55.44 million | Q2 2018: $55.55 million | Q3 2018: $54.85 million | Q1 2019: $55.65 million | Q2 2019: $56.44 million | Q3 2019: $61.15 million | Q1 2020: $89.33 million | Q2 2020: $95.92 million | Q3 2020: $247.31 million | Q1 2021: $999.08 million | Q2 2021: $1.05 billion | Q3 2021: $1.20 billion | Q1 2022: $1.47 billion | Q2 2022: $1.46 billion | Q3 2022: $1.41 billion | Q1 2023: $1.38 billion | Q2 2023: $1.35 billion | Q3 2023: $1.36 billion | Q1 2024: $1.23 billion | Q2 2024: $1.23 billion | Q3 2024: $1.23 billion | Q1 2025: $1.21 billion | Q2 2025: $1.20 billion | Q3 2025: $1.21 billion.
- Over the full 11 years of available data (2015 to 2025), Fulgent Genetics, Inc.'s Total Assets has grown by 20,708.0%.
- Historical annual values: Fiscal year 2025: $1.21 billion | Fiscal year 2024: $1.22 billion | Fiscal year 2023: $1.24 billion | Fiscal year 2022: $1.39 billion | Fiscal year 2021: $1.28 billion | Fiscal year 2020: $700.46 million | Fiscal year 2019: $88.76 million | Fiscal year 2018: $53.90 million | Fiscal year 2017: $57.18 million | Fiscal year 2016: $58.04 million | Fiscal year 2015: $5.83 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: